CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 80 enrolled
Drug / intervention
without dye varicocelectomy +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01259258
NCT01259258Phase 2Completed

Dye Assisted Lymphatic Sparing Varicocelectomy,Prospective Randomized Study

Mansoura University·interventional·Posted Dec 14, 2010·Updated Dec 14, 2010

In Brief

A Phase 2 clinical trial evaluating without dye varicocelectomy for Varicocele. Completed, enrolled 80 participants across 1 site.

Detailed Summary

We prospectively compared outcomes of subinguinal varicocelectomy for 40 patients who received 2 ml intratunical space injection of methylene blue before spermatic vein ligation with 40 controls in whom no mapping technique was adopted in the period between January 2008 and Feb. 2010, in Mansoura university hospital ward 7.After surgery, the patients were assessed at 2 weeks,6 and 12 months for varicocele recurrence, hydrocele formation, atrophy, pain or other complications with mean follow up was 15+ 7months.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVaricocele
CountriesEgypt
Collaborators--

Timeline

Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedDec 14, 2010
Enrollment StartJan 1, 2008
Primary CompletionFeb 1, 2010
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 15.5 years ago

Interventions

without dye varicocelectomyprocedure

40 controls in whom no mapping technique was adopted in the period between

without dye varicocelectomyprocedure

40 controls in whom no mapping technique was adopted in the period between